SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-153632
Filing Date
2009-07-23
Accepted
2009-07-23 08:50:49
Documents
6
Period of Report
2009-07-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15717
2 PLACEMENT AGENCY AGREEMENT dex11.htm EX-1.1 113847
3 OPINION OF WYRICK ROBBINS YATES & PONTON LLP dex51.htm EX-5.1 6536
4 FORM OF SUBSCRIPTION AGREEMENT dex1014.htm EX-10.14 57870
5 PRESS RELEASE DATED JULY 23, 2009 dex991.htm EX-99.1 7002
6 GRAPHIC g77616g95i07.jpg GRAPHIC 30370
  Complete submission text file 0001193125-09-153632.txt   244574
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 09958234
SIC: 2836 Biological Products, (No Diagnostic Substances)